Atlas Trials

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Clinical trial NCT01105611 · UNKNOWN

Trial details

NCT number
NCT01105611
Sponsor
St. James's Hospital, Ireland
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HIV InfectionsHepatitis C
Start date
2010-08-01
Primary completion
2012-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.